PHENYTOIN DOSAGE INDIVIDUALIZATION - 5 METHODS COMPARED IN THE ELDERLY

被引:14
作者
HUDSON, SA
FARQUHAR, DL
THOMPSON, D
SMITH, RG
机构
[1] WESTERN GEN HOSP,LOTHIAN HLTH BOARD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
[2] WESTERN GEN HOSP,DEPT GERIATR MED,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND
关键词
D O I
10.1111/j.1365-2710.1990.tb00352.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Five methods to predict phenytoin dosage have been compared in nine continuous care elderly patients. For each patient three steady‐state plasma concentrations were obtained at three different doses. The data were used to estimate the ‘optimum’ dose for each patient by direct linear plot. The optimum dose for each patient was predicted from each plasma concentration using five dosage prediction methods based on the Michaelis‐Menten equation using: (i) the population mean Vmax, (ii) the population mean KM, (iii) the linearized Bayesian method, (iv) the Rambeck nomogram, and (v) two plasma concentration‐dose data pairs to estimate both Vmax and KM. The predictive precision was similar for each of methods (i‐iv). Ninety‐six out of 126 dosage predictions with the five methods were within 25 mg of the optimum dose. Methods (ii) and (iv) tended to overpredict dosage, particularly when used to interpret low plasma phenytoin concentrations. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:25 / 34
页数:10
相关论文
共 14 条
[1]   COMPARISON OF 8 PHENYTOIN DOSING METHODS IN INSTITUTIONALIZED PATIENTS [J].
FLINT, N ;
LOPEZ, LM ;
ROBINSON, JD ;
WILLIAMS, C ;
SALEM, RB .
THERAPEUTIC DRUG MONITORING, 1985, 7 (01) :74-80
[2]   STEADY-STATE PHARMACOKINETICS OF PHENYTOIN FROM ROUTINELY COLLECTED PATIENT DATA [J].
GRASELA, TH ;
SHEINER, LB ;
RAMBECK, B ;
BOENIGK, HE ;
DUNLOP, A ;
MULLEN, PW ;
WADSWORTH, J ;
RICHENS, A ;
ISHIZAKI, T ;
CHIBA, K ;
MIURA, H ;
MINAGAWA, K ;
BLAIN, PG ;
MUCKLOW, JC ;
BACON, CT ;
RAWLINS, M .
CLINICAL PHARMACOKINETICS, 1983, 8 (04) :355-364
[3]  
MACGEE J, 1971, ANAL CHEM, V42, P421
[4]   COMPARATIVE-ANALYSIS OF THE PHARMACOKINETIC TECHNIQUES AVAILABLE FOR INDIVIDUALIZING PHENYTOIN DOSAGE [J].
MESSORI, A ;
ZACCARA, G ;
VALENZA, T ;
ARNETOLI, G ;
BARTOLI, C ;
DONATICORI, G ;
MUSCAS, GC ;
TENDI, E .
JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1983, 8 (04) :357-365
[5]  
MULLEN PW, 1978, CLIN PHARMACOL THER, V23, P228
[6]   CLINICAL UTILITY OF 6 METHODS OF PREDICTING PHENYTOIN DOSES AND PLASMA-CONCENTRATIONS [J].
MURPHY, JE ;
BRUNI, J ;
STEWART, RB .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (03) :348-354
[7]  
RAMBECK B, 1979, THER DRUG MONIT, V3, P325
[8]  
RICHENS A, 1971, LANCET, V2, P1305
[9]   SOME SUGGESTIONS FOR MEASURING PREDICTIVE PERFORMANCE [J].
SHEINER, LB ;
BEAL, SL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (04) :503-512
[10]  
TOSCANO JP, 1986, CLIN PHARMACY, V5, P396